Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 02, 2022
Share
Nang Kuang Pharmaceutical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 472.86 million compared to TWD 442.7 million a year ago. Net income was TWD 74.61 million compared to TWD 54.26 million a year ago. Basic earnings per share from continuing operations was TWD 0.74 compared to TWD 0.54 a year ago. Diluted earnings per share from continuing operations was TWD 0.74 compared to TWD 0.54 a year ago.
For the six months, sales was TWD 848.61 million compared to TWD 865.8 million a year ago. Net income was TWD 115.63 million compared to TWD 99.05 million a year ago. Basic earnings per share from continuing operations was TWD 1.14 compared to TWD 0.98 a year ago. Diluted earnings per share from continuing operations was TWD 1.14 compared to TWD 0.98 a year ago.
NANG KUANG PHARMACEUTICAL CO., LTD. is principally engaged in the manufacture, processing and trading of western medicine. The company main products include injections, sterile injections, powder injections, hard capsules, bare ingots, film ingots, casing ingots, granules and creams, among others. The Company is also engaged in the manufacture, processing and trading of medical equipment. The Company distributes its products within the domestic market and to overseas markets.